New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - irinotecan hydrochloride trihydrate 20 mg/ml;   - solution for injection - 20 mg/ml - active: irinotecan hydrochloride trihydrate 20 mg/ml   excipient: lactic acid sodium hydroxide sorbitol water for injection - irinotecan ebewe is indicated for the first line treatment of patients with metastatic carcinoma of the colon or rectum, in combination with 5fu/leucovorin. irinotecan ebewe is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - irinotecan hydrochloride trihydrate 20 mg/ml ((equivalent to 17.33 mg irinotecan));   - solution for infusion - 20 mg/ml - active: irinotecan hydrochloride trihydrate 20 mg/ml ((equivalent to 17.33 mg irinotecan))   excipient: hydrochloric acid lactic acid sodium hydroxide sorbitol water for injection - irinotecan hydrochloride trihydrate injection is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum, in combination with 5fu/leucovorin. irinotecan hydrochloride trihydrate injection is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

hikma farmacêutica s.a. - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - irinotecan

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

hikma farmacêutica s.a. - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - irinotecan

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

hikma farmacêutica s.a. - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - irinotecan

Malta - English - Medicines Authority

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - irinotecan hydrochloride, trihydrate - concentrate for solution for infusion - irinotecan hydrochloride trihydrate 20 mg/ml - antineoplastic agents

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eugia pharma (malta) ltd. - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - irinotecan

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eugia pharma (malta) ltd. - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - irinotecan

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eugia pharma (malta) ltd. - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - irinotecan

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eugia pharma (malta) ltd. - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - irinotecan